GT Biopharma (GTBP) News Today → The Only Energy Play You Should Be Looking At (From Wealthpin Pro) (Ad) Free GTBP Stock Alerts $3.75 -0.11 (-2.85%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 21, 2024 | marketwatch.comGT Biopharma Shares Rise 16% After Direct Offering PricesMay 21, 2024 | markets.businessinsider.comGT Biopharma Announces $3.2 Mln Direct Offering Of Shares; Stock UpMay 21, 2024 | globenewswire.comGT Biopharma, Inc. Announces $3.2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesMay 20, 2024 | investorplace.comWhy Is GT Biopharma (GTBP) Stock Up 143% Today?May 18, 2024 | nasdaq.comGT Biopharma, Inc. Common Stock (GTBP)May 16, 2024 | benzinga.comRaymond W. Urbanski's Net WorthMay 16, 2024 | investorplace.comGTBP Stock Earnings: GT Biopharma Beats EPS for Q1 2024May 15, 2024 | msn.comGT Biopharma reports Q1 resultsMay 15, 2024 | globenewswire.comGT Biopharma Reports First Quarter 2024 Financial Results and Provides Corporate UpdateMarch 27, 2024 | benzinga.comRecap: GT Biopharma Q4 EarningsMarch 26, 2024 | globenewswire.comGT Biopharma Reports Fourth Quarter and Full-Year 2023 Financial ResultsFebruary 25, 2024 | msn.comGT Biopharma (GTBP) Price Target Increased by 2900.00% to 153.00February 14, 2024 | finance.yahoo.comGTBP Feb 2024 2.500 callFebruary 5, 2024 | marketbeat.comTrading was temporarily halted for "GTBP" at 07:02 PM with a stated reason of "News pending."February 2, 2024 | finance.yahoo.comGT Biopharma, Inc. (GTBP)February 2, 2024 | msn.comGT Biopharma Announces Reverse Stock Split UpdateFebruary 2, 2024 | benzinga.comGT Biopharma Stock (NASDAQ:GTBP), Short Interest ReportFebruary 1, 2024 | finance.yahoo.comGT Biopharma, Inc. Announces 1-for-30 Reverse Stock SplitDecember 14, 2023 | markets.businessinsider.comBuy Rating for GT Biopharma: High Efficacy and Expanded Potential in Oncology TherapeuticsDecember 6, 2023 | finance.yahoo.comLeading Proxy Advisory Firms, ISS and Glass Lewis, Recommend GT Biopharma Stockholders Vote “FOR” All Proposed Items at the Upcoming Special Meeting of StockholdersDecember 4, 2023 | msn.comGT Biopharma submits IND to FDA for CD33+ leukemia therapyDecember 4, 2023 | finance.yahoo.comGT Biopharma Announces IND Submission for GTB-3650 for Treatment of CD33+ LeukemiaNovember 23, 2023 | markets.businessinsider.comGT Biopharma: Strong Q3 Performance and Promising Pipeline Progression Justify Buy RatingNovember 6, 2023 | finance.yahoo.comGT Biopharma Presented Positive Preclinical Data for GTB-5550, a Novel TriKE® Molecule for Targeted Prostate Cancer Treatment During the Society for Immunotherapy of Cancer (SITC) 2023 Annual MeetingNovember 1, 2023 | msn.comGT Biopharma GAAP EPS of -$0.06November 1, 2023 | finance.yahoo.comGT Biopharma Reports Third Quarter 2023 Financial ResultsAugust 24, 2023 | finance.yahoo.comGT Biopharma, Inc. (GTBP) May Find a Bottom Soon, Here's Why You Should Buy the Stock NowAugust 8, 2023 | markets.businessinsider.comH.C. Wainwright Remains a Buy on GT Biopharma (GTBP)August 7, 2023 | finanznachrichten.deGT Biopharma, Inc.: GT Biopharma Reports Second Quarter 2023 Financial ResultsAugust 7, 2023 | finance.yahoo.comGT Biopharma Reports Second Quarter 2023 Financial ResultsAugust 3, 2023 | finance.yahoo.comGT Biopharma to Participate in the H.C. Wainwright Immune Cell Engager Conference on August 17, 2023June 2, 2023 | msn.comHere's Why GT Biopharma, Inc. (GTBP) Is a Great 'Buy the Bottom' Stock NowMay 19, 2023 | msn.comAll You Need to Know About GT Biopharma, Inc. (GTBP) Rating Upgrade to BuyMay 18, 2023 | msn.comHC Wainwright & Co. Reiterates GT Biopharma (GTBP) Buy RecommendationMay 17, 2023 | msn.comEF Hutton Reiterates GT Biopharma (GTBP) Hold RecommendationMay 16, 2023 | finanznachrichten.deGT Biopharma, Inc.: GT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate UpdateMay 16, 2023 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Cara Therapeutics (CARA), GT Biopharma (GTBP) and Spruce Biosciences (SPRB)May 15, 2023 | finance.yahoo.comGT Biopharma Reports First Quarter 2023 Financial Results and Provides Corporate UpdateApril 3, 2023 | markets.businessinsider.comGT Biopharma (GTBP) Gets a Buy from H.C. WainwrightApril 2, 2023 | benzinga.comGT Biopharma Inc Up 20.52% To $0.56 After Earnings MissApril 1, 2023 | finanznachrichten.deGT Biopharma, Inc.: GT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate UpdateApril 1, 2023 | benzinga.comGT Biopharma Stock (NASDAQ:GTBP), DividendsMarch 31, 2023 | markets.businessinsider.comEF Hutton Keeps Their Hold Rating on GT Biopharma (GTBP)March 30, 2023 | finance.yahoo.comGT Biopharma Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Corporate UpdateFebruary 24, 2023 | finance.yahoo.comGT Biopharma to Participate in the H.C. Wainwright Cell Therapy Virtual ConferenceFebruary 2, 2023 | finance.yahoo.comGT Biopharma Issues Open Letter to Shareholders Detailing Recent ActivitiesDecember 30, 2022 | msn.comGT Biopharma slips on $6.5M stock offeringDecember 14, 2022 | finance.yahoo.comGT Biopharma Names Dr. Jeff Miller as Consulting Chief Medical OfficerDecember 12, 2022 | msn.comFate Therapeutics hits 52-week low after preclinical data on leukemia treatmentDecember 12, 2022 | finance.yahoo.comGT Biopharma and Fate Therapeutics Present Preclinical Data Highlighting Novel Dual Antigen Targeting Approach For The Treatment of AML at ASH 2022 Get GT Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GTBP and its competitors with MarketBeat's FREE daily newsletter. Email Address The Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy. Click here to get all the information about it. GTBP Media Mentions By Week GTBP Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. GTBP News Sentiment▼1.510.76▲Average Medical News Sentiment GTBP News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. GTBP Articles This Week▼20▲GTBP Articles Average Week Get GT Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for GTBP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Purple Biotech News Vincerx Pharma News MEI Pharma News Synlogic News Lumos Pharma News KALA BIO News Talphera News Orgenesis News Alaunos Therapeutics News VBI Vaccines News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:GTBP) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProThe #1 Crypto That You Don’t Own… YetCrypto 101 MediaBiden Nomination CANCELED?The Freeport SocietyWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsElon to Transform U.S. Economy? Porter & CompanyBiden replacement revealed?Paradigm Press Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding GT Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.